In the 104-patient, phase 3 trial, a daily oral dose of tinlarebant achieved the primary efficacy endpoint by demonstrating a ...

An agreement between the UK and the US will maintain tariffs on imports into the US at 0% but, as a quid pro quo, prices of ...

The five-year SURMOUNT-REAL UK trial, part of a collaboration signed last year between Lilly and the UK government, will ...

Critical information sits scattered across disconnected databases. Analysis that should take hours stretches into weeks as ...

At the BIO-Europe congress in Vienna, the session titled “From Roasts to Billions: Biopharma Investment Landscape” brought ...

The EMA has started a review of a regimen based on Pfizer and Astellas' Padcev and MSD's Keytruda that has been described as ...

The source of the reports is an internal email to CBER staff in which Prasad said that, in a "profound revelation," the US ...

The Clinical Data Research Report shows data managers are currently losing an estimated 12 hours per week per study to ...

Prostate cancer screening should not be made available to the vast majority of men across the UK, according to a committee set up to recommend a screening policy for the health service.

Kelonia Therapeutics only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but already has ...

Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

The FDA has started a priority review of BeOne Medicines' BCL2 inhibitor sonrotoclax in relapsed or refractory mantle cell ...